Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Grivas PD"'
Autor:
Bachegowda LS, Nagaraj G, Grivas PD, Chen L, Choi E, Styler M, Bachegowda, Lohith S, Nagaraj, Gayathri, Grivas, Petros D, Chen, Lingyi, Choi, Eugene, Styler, Michael
Publikováno v:
Medical Oncology; Sep2010, Vol. 27 Issue 3, p876-879, 4p
Autor:
Trinity J. Bivalacqua, Bernd J. Schmitz-Dräger, Felix Wezel, Marta Sanchez-Carbayo, Bas W.G. van Rhijn, Andrea Necchi, Petros Grivas, Kim E.M. van Kessel, Anne E. Kiltie, Thorsten H. Ecke, Florian Roghmann, Joost L. Boormans, Ashish M. Kamat, Tahlita C.M. Zuiverloon, Fredrik Liedberg
Publikováno v:
Urologic Oncology-Seminars and Original Investigations, 36(9), 423-431. Elsevier Inc.
Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladder cancer (MIBC). However, most only briefly mention follow-up strategies for patients and hence the treating physician is often left to in
Autor:
Balar, Arjun V, Galsky, Matthew D, Rosenberg, Jonathan E, Powles, Thomas, Petrylak, Daniel P, Bellmunt, Joaquim, Loriot, Yohann, Necchi, Andrea, Hoffman-Censits, Jean, Perez-Gracia, Jose Luis, Dawson, Nancy A, van der Heijden, Michiel S, Dreicer, Robert, Srinivas, Sandy, Retz, Margitta M, Joseph, Richard W, Drakaki, Alexandra, Vaishampayan, Ulka N, Sridhar, Srikala S, Quinn, David I, Durán, Ignacio, Shaffer, David R, Eigl, Bernhard J, Grivas, Petros D, Yu, Evan Y, Li, Shi, Kadel, Edward E, Boyd, Zachary, Bourgon, Richard, Hegde, Priti S, Mariathasan, Sanjeev, Thåström, AnnChristine, Abidoye, Oyewale O, Fine, Gregg D, Bajorin, Dean F, IMvigor210 Study Group
Summary Background First-line chemotherapy for patients with cisplatin-ineligible locally advanced or metastatic urothelial carcinoma is associated with short response duration, poor survival, and high toxicity. This study assessed atezolizumab (anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a6a5d4e1d8b7a8b214348187af3dbd
https://hdl.handle.net/10668/10669
https://hdl.handle.net/10668/10669
Autor:
Mentis AA; Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece.; Department of Microbiology, University Hospital of Thessaly, Larissa, Greece., Grivas PD; Division of Oncology, Department of Medicine, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Dardiotis E; Department of Neurology, University Hospital of Thessaly, Larissa, Greece., Romas NA; Department of Urology, Columbia University Medical Center, Vagelos College of Physicians and Surgeons, New York, NY, USA., Papavassiliou AG; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 M. Asias Street-Bldg. 16, 11527, Athens, Greece. papavas@med.uoa.gr.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2020 Sep; Vol. 77 (18), pp. 3671-3690. Date of Electronic Publication: 2020 Apr 24.
Autor:
Zuiverloon TCM; Department of Urology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands; University of Colorado Comprehensive Cancer Center, Aurora, CO., van Kessel KEM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Bivalacqua TJ; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MA., Boormans JL; Department of Urology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Ecke TH; Department of Urology, HELIOS Hospital, Bad Saarow, Germany., Grivas PD; Department of Hematology/Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Kiltie AE; Department of Oncology, University of Oxford, Oxford, UK., Liedberg F; Department of Urology, Skåne University Hospital, Lund, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden., Necchi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., van Rhijn BW; Division of Surgical Oncology (Urology), Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands., Roghmann F; Department of Urology, Ruhr-University, Bochum, Germany., Sanchez-Carbayo M; Lucio Lascaray Research Center, University of the Basque Country, Vitoria-Gasteiz, Spain., Schmitz-Dräger BJ; Department of Urology, Friedrich-Alexander University, Erlangen and Urologie24, Nuremberg, Germany., Wezel F; Department of Urology, Ulm University Hospital, Ulm, Germany., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: akamat@mdanderson.org.
Publikováno v:
Urologic oncology [Urol Oncol] 2018 Sep; Vol. 36 (9), pp. 423-431. Date of Electronic Publication: 2018 Mar 02.
Autor:
Grivas PD; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Desk R35, 9500 Euclid Ave, Cleveland, OH, 44195, USA. grivasp@ccf.org., Devata S; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Khoriaty R; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Boonstra PS; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., Ruch J; Hematology/Oncology, Munson Medical Center, Traverse City, MI, USA., McDonnell K; Division of Hematology/Oncology, University of Southern California, Los Angeles, CA, USA., Hernandez-Aya L; Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA., Wilfong J; Hospice and Palliative Medicine, Stanford University, Stanford, CA, USA., Smerage J; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Ison MG; Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Eisenberg JNS; Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA., Silveira M; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Cooney KA; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.; Department of Urology, University of Michigan, Ann Arbor, MI, USA., Worden FP; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
Publikováno v:
Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2017 Dec; Vol. 32 (4), pp. 871-877.
Autor:
Balar AV; Genitourinary Cancers Program, Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA. Electronic address: arjun.balar@nyumc.org., Galsky MD; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rosenberg JE; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Powles T; Barts Cancer Institute ECMC, Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK., Petrylak DP; Smilow Cancer Center, Yale University, New Haven, CT, USA., Bellmunt J; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Loriot Y; Département de médecine oncologique, Université Paris-Saclay and Gustave Roussy, Villejuif, France., Necchi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Hoffman-Censits J; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA., Perez-Gracia JL; Department of Oncology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Navarre, Spain., Dawson NA; Medstar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA., van der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Dreicer R; Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA., Srinivas S; Division of Oncology/Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Retz MM; Department of Urology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Joseph RW; Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA., Drakaki A; Department of Medicine, Division of Hematology and Oncology and Institute of Urologic Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Vaishampayan UN; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Sridhar SS; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada., Quinn DI; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Durán I; Department of Medical Oncology, Hospital Universitario Virgen del Rocío and Institute of Biomedicine of Seville, Seville, Spain., Shaffer DR; New York Oncology Hematology, Albany, NY, USA., Eigl BJ; British Columbia Cancer Agency, British Columbia, Vancouver, Canada., Grivas PD; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Yu EY; Division of Oncology, Department of Medicine, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Li S; Genentech, South San Francisco, CA, USA., Kadel EE 3rd; Genentech, South San Francisco, CA, USA., Boyd Z; Genentech, South San Francisco, CA, USA., Bourgon R; Genentech, South San Francisco, CA, USA., Hegde PS; Genentech, South San Francisco, CA, USA., Mariathasan S; Genentech, South San Francisco, CA, USA., Thåström A; Genentech, South San Francisco, CA, USA., Abidoye OO; Genentech, South San Francisco, CA, USA., Fine GD; Genentech, South San Francisco, CA, USA., Bajorin DF; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2017 Jan 07; Vol. 389 (10064), pp. 67-76. Date of Electronic Publication: 2016 Dec 08.
Autor:
Zargar-Shoshtari K; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive Office 12538, Tampa, FL, 33612, USA., Zargar H; Vancouver Prostate Centre, Vancouver, BC, Canada., Dinney CP; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., Ercole CE; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Sharma P; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive Office 12538, Tampa, FL, 33612, USA., Kovac E; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Grivas PD; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Stephenson AJ; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Shah JB; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., Black PC; Vancouver Prostate Centre, Vancouver, BC, Canada., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive Office 12538, Tampa, FL, 33612, USA. philippe.spiess@moffitt.org.
Publikováno v:
World journal of urology [World J Urol] 2016 May; Vol. 34 (5), pp. 695-701. Date of Electronic Publication: 2015 Aug 19.
Autor:
Grivas PD; Taussig Cancer Institute, Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH 44195, USA., Melas M; USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA., Papavassiliou AG; Department of Biological Chemistry, University of Athens, Medical School, 11527 Athens, Greece. Electronic address: papavas@med.uoa.gr.
Publikováno v:
Seminars in cancer biology [Semin Cancer Biol] 2015 Dec; Vol. 35, pp. 125-32. Date of Electronic Publication: 2015 Aug 22.
Autor:
Zhao B; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Desk R30, 9500 Euclid Avenue, Cleveland, OH 44195, USA., Grivas PD; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Desk R35, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Electronic address: grivasp@ccf.org.
Publikováno v:
Clinics in geriatric medicine [Clin Geriatr Med] 2015 Nov; Vol. 31 (4), pp. 645-65. Date of Electronic Publication: 2015 Aug 13.